0001209191-18-010105.txt : 20180214
0001209191-18-010105.hdr.sgml : 20180214
20180214180640
ACCESSION NUMBER: 0001209191-18-010105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180212
FILED AS OF DATE: 20180214
DATE AS OF CHANGE: 20180214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18614741
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-12
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2018-02-12
4
S
0
6100
149.22
D
208463
D
Common Stock
2018-02-12
4
S
0
4305
150.44
D
204158
D
Common Stock
2018-02-12
4
S
0
10100
151.23
D
194058
D
Common Stock
2018-02-12
4
S
0
1200
152.40
D
192858
D
Common Stock
2018-02-12
4
S
0
2000
153.29
D
190858
D
Common Stock
2018-02-12
4
S
0
200
153.89
D
190658
D
Common Stock
440
I
401(k)
Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $149.22 (range $148.77 to $149.74).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $150.44 (range $149.79 to $150.76).
Open market sales reported on this line occurred at a weighted average price of $151.23 (range $150.83 to $151.82).
Open market sales reported on this line occurred at a weighted average price of $152.40 (range $151.85 to $152.81).
Open market sales reported on this line occurred at a weighted average price of $153.29 (range $152.88 to $153.84).
Open market sales reported on this line occurred at a weighted average price of $153.89 (range $153.88 to $153.89).
/s/ Omar White, Attorney-in-Fact
2018-02-14